APA (7th ed.) Citation

BR, H., A, B. W., FY, Z., A, H., P, B., AK, D., . . . VM, R. (2021). Immune checkpoint inhibitors in patients with pre-existing psoriasis: Safety and efficacy. Journal for immunotherapy of cancer, 9(10), . https://doi.org/10.1136/jitc-2021-003066

Chicago Style (17th ed.) Citation

BR, Halle, et al. "Immune Checkpoint Inhibitors in Patients with Pre-existing Psoriasis: Safety and Efficacy." Journal for Immunotherapy of Cancer 9, no. 10 (2021). https://doi.org/10.1136/jitc-2021-003066.

MLA (9th ed.) Citation

BR, Halle, et al. "Immune Checkpoint Inhibitors in Patients with Pre-existing Psoriasis: Safety and Efficacy." Journal for Immunotherapy of Cancer, vol. 9, no. 10, 2021, https://doi.org/10.1136/jitc-2021-003066.